9 May 2019 - Administration’s proposed rule on rebates increases prescription drug prices, disrupts consumer access.

“We stand with Congress and the Administration in the fight to reduce prescription drug costs. To achieve that objective, it is important to understand the role of each player in the prescription drug supply chain, including drug manufacturers, wholesalers, and pharmacy services administrative organisations, in addition to the pharmacy benefit managers (PBMs) that work every day to reduce costs for consumers. We commend the Subcommittee for holding the hearing.

Drug manufacturers alone set and raise drug prices. As the only check on manufacturers’ pricing power, PBMs have been able to achieve an overall stable cost trend for prescription drugs.

Read Pharmaceutical Care Management Association press release